HeartMate-3 Ventricular Assist Devices Versus the Total Artificial Heart for Biventricular Support: A Single-Center Series
The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a biventricular configuration (BiVAD) have been used with variable results. The purpose of this report was to examine differences in patient character...
Saved in:
Published in | ASAIO journal (1992) Vol. 69; no. 6; p. 544 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2023
|
Online Access | Get more information |
Cover
Loading…
Abstract | The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a biventricular configuration (BiVAD) have been used with variable results. The purpose of this report was to examine differences in patient characteristics and outcomes between two HeartMate-3 (HM-3) VADs in comparison with TAH support.
All patients who received durable biventricular mechanical support from November 2018 to May 2022 at The Mount Sinai Hospital (New York) were considered. Baseline clinical, echocardiographic, hemodynamic, and outcome data were extracted. Primary outcomes were postoperative survival and successful bridge-to-transplant (BTT).
A total of 16 patients received durable biventricular mechanical support during the study period, of which 6 (38%) patients received two HM-3 VAD pumps as BiVAD support and 10 (62%) patients received a TAH. Overall, TAH patients had a lower median lactate ( p < 0.05) at baseline compared to those on HM-3 BiVAD support yet had higher operative morbidity, lower 6-month survival ( p < 0.05), and a higher rate of renal failure (80 vs . 17%; p = 0.03). However, survival declined to the same rate at 1 year (50%) and was largely because of extracardiac adverse events related to underlying comorbidities (particularly, renal failure and diabetes, p < 0.05). Successful BTT was achieved in 3 out of 6 HM-3 BiVAD patients and in 5 out of 10 TAH patients.
In our single center experience, similar outcomes were observed among patients BTT with HM-3 BiVAD compared to those BTT on TAH support despite lower Interagency Registry for Mechanically Assisted Circulatory Support level. |
---|---|
AbstractList | The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a biventricular configuration (BiVAD) have been used with variable results. The purpose of this report was to examine differences in patient characteristics and outcomes between two HeartMate-3 (HM-3) VADs in comparison with TAH support.
All patients who received durable biventricular mechanical support from November 2018 to May 2022 at The Mount Sinai Hospital (New York) were considered. Baseline clinical, echocardiographic, hemodynamic, and outcome data were extracted. Primary outcomes were postoperative survival and successful bridge-to-transplant (BTT).
A total of 16 patients received durable biventricular mechanical support during the study period, of which 6 (38%) patients received two HM-3 VAD pumps as BiVAD support and 10 (62%) patients received a TAH. Overall, TAH patients had a lower median lactate ( p < 0.05) at baseline compared to those on HM-3 BiVAD support yet had higher operative morbidity, lower 6-month survival ( p < 0.05), and a higher rate of renal failure (80 vs . 17%; p = 0.03). However, survival declined to the same rate at 1 year (50%) and was largely because of extracardiac adverse events related to underlying comorbidities (particularly, renal failure and diabetes, p < 0.05). Successful BTT was achieved in 3 out of 6 HM-3 BiVAD patients and in 5 out of 10 TAH patients.
In our single center experience, similar outcomes were observed among patients BTT with HM-3 BiVAD compared to those BTT on TAH support despite lower Interagency Registry for Mechanically Assisted Circulatory Support level. |
Author | Mancini, Donna Satish, Mohan Roldan, Julie Moss, Noah Itagaki, Shinobu Anyanwu, Anelechi Lala, Anuradha |
Author_xml | – sequence: 1 givenname: Mohan surname: Satish fullname: Satish, Mohan organization: From the Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai – sequence: 2 givenname: Anelechi surname: Anyanwu fullname: Anyanwu, Anelechi organization: Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai – sequence: 3 givenname: Noah surname: Moss fullname: Moss, Noah organization: From the Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai – sequence: 4 givenname: Anuradha surname: Lala fullname: Lala, Anuradha organization: Department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai – sequence: 5 givenname: Shinobu surname: Itagaki fullname: Itagaki, Shinobu organization: Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai – sequence: 6 givenname: Julie surname: Roldan fullname: Roldan, Julie organization: From the Division of Cardiology, Department of Medicine, Icahn School of Medicine at Mount Sinai – sequence: 7 givenname: Donna orcidid: 0000-0002-6050-1785 surname: Mancini fullname: Mancini, Donna organization: Department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36867839$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkMtOwzAQRS0Eog_4A4T8Aym2J3FidqE8itSKRQNiV7nOBIzSJLKdSvD1RDykzuZe3SOdxUzIcdM2SMgFZzPOVHq1yosZOziuGDsiY55AFqkYXkdk4v3HsCcA_JSMQGYyzUCNydcCtQsrHTAC-oJNcNb0tXY09976QG9xbw36ATnfexrekRZt0DXNXbCVNXaoPwpatY7e2P2BYt13XevCNc3p2jZvNUbzgeIA0Fn0Z-Sk0rXH87-ckuf7u2K-iJZPD4_zfBkZYGmIQDI0UCmWbTNIykxzpXWiMTVQgkhTWaaJVpKBYCiFjmXMhRTGJJXUUsZGTMnlr7frtzssN52zO-0-N_9PEN8n22AW |
CitedBy_id | crossref_primary_10_1016_j_bbe_2023_12_005 crossref_primary_10_1093_icvts_ivad139 |
ContentType | Journal Article |
Copyright | Copyright © ASAIO 2023. |
Copyright_xml | – notice: Copyright © ASAIO 2023. |
DBID | NPM |
DOI | 10.1097/MAT.0000000000001900 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-943X |
ExternalDocumentID | 36867839 |
Genre | Journal Article |
GroupedDBID | --- .-D .XZ .Z2 0R~ 23N 4Q1 4Q2 4Q3 5GY 5RE 5VS AAAAV AAHPQ AAIQE AAJCS AAMTA AARTV AASCR AAYEP ABASU ABBUW ABDIG ABJNI ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACILI ACWDW ACWRI ACXJB ACXNZ ADGGA ADHPY AEBDS AENEX AFDTB AFEXH AGINI AHQNM AHRYX AHVBC AINUH AJIOK AJNWD ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BQLVK C45 CS3 DIWNM E.X EBS EEVPB EX3 F2K F2L F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ IPNFZ JK3 JK8 K8S KD2 KMI L-C N9A NPM O9- OAG OAH ODA ODMTH OHYEH OK1 OL1 OLG OLV OLZ OPUJH OVD OVDNE OWW OWY OXXIT P2P RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M WH7 WOQ WOW X3V X3W YFH ZFV ZGI |
ID | FETCH-LOGICAL-c307t-360ec3f908b835d8a19aa5ae7c3d32776d75a960320e62a4641262cc5f6a664c2 |
IngestDate | Thu May 23 23:32:13 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | Copyright © ASAIO 2023. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c307t-360ec3f908b835d8a19aa5ae7c3d32776d75a960320e62a4641262cc5f6a664c2 |
ORCID | 0000-0002-6050-1785 |
PMID | 36867839 |
ParticipantIDs | pubmed_primary_36867839 |
PublicationCentury | 2000 |
PublicationDate | 2023-06-01 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | ASAIO journal (1992) |
PublicationTitleAlternate | ASAIO J |
PublicationYear | 2023 |
SSID | ssj0015331 |
Score | 2.3875544 |
Snippet | The SynCardia total artificial heart (TAH) is the only device approved for biventricular support. Continuous flow ventricular assist devices (VAD) in a... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 544 |
Title | HeartMate-3 Ventricular Assist Devices Versus the Total Artificial Heart for Biventricular Support: A Single-Center Series |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36867839 |
Volume | 69 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa6IU17QdxhXOQH3iaP1HbshLcMgQoi5aEd2tvkOI5aaUunkmra_s7-KMeXXDYGAvqQVnFlVf6-Hh-fnPMdhN7yopJCGEa0MJRwLiOiaKqJKjW8RUVaSVucnE_F5Ih_OY6PR6PrQdbSpikO9NWddSX_gyrcA1xtlew_INtNCjfgM-ALV0AYrn-F8QRo2uTgLRK2_92GaZc-qxTWHNCzCUHWDOzbmNjmh3Mx5ytb_JitXYbQ0gsLrxuXa3ho7V43he32aZvMu8L1Gexvp4bYSLBZW_PSZh628rWz7PO3ToTCSj-lKR3EGGa2hMLFb_LVoqdjVl-q-mLj8yptP57FssM_NHOfrvp49Vd16oPA9WatyoUaBiwo6xOrDszAyHLXB7izwr5hS2Db0KTGXh_yF1PvJYTzbO4lKMML_Jto-HVYpvMzBz8TCWzMXjnpz6O3BLjboS20JRNrRKc2IBQeVIG3PG4rMlP57q6fs4t22ilunV2cDzN_gO6HwwfOPJMeopGpH6GdPKRXPEZXA0LhAaGwJxQOhMKeUBgIhR2hcE8o7KbAQCh8g1A4EOo9zvANOmFPpyfo6NPH-YcJCc05iIZtoSFMREazKo2SApz4MlHjVKlYGalZyaiUopSxguMxo5ERVHHBx1RQreNKKCG4pk_Rdr2qzXOEE6FSZqKoqsaGw4E9TeAMo2QVG5HwMjYv0DO_aifnXoHlpF3Pvd-OvES7PfdeoXsV_OXNa_Afm-KNQ_AnoI1tjQ |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HeartMate-3+Ventricular+Assist+Devices+Versus+the+Total+Artificial+Heart+for+Biventricular+Support%3A+A+Single-Center+Series&rft.jtitle=ASAIO+journal+%281992%29&rft.au=Satish%2C+Mohan&rft.au=Anyanwu%2C+Anelechi&rft.au=Moss%2C+Noah&rft.au=Lala%2C+Anuradha&rft.date=2023-06-01&rft.eissn=1538-943X&rft.volume=69&rft.issue=6&rft.spage=544&rft_id=info:doi/10.1097%2FMAT.0000000000001900&rft_id=info%3Apmid%2F36867839&rft_id=info%3Apmid%2F36867839&rft.externalDocID=36867839 |